what-we-do 
pharmaphorum
JUNE 17, 2022
As COVID-19 cases rise once again and the federal government gears up to increase distribution of Paxlovid, we thought we’d take this opportunity to review information about the drug and share new information that has come to light since it was first approved. What is Paxlovid and how was it developed? What are its side effects?
STAT
OCTOBER 10, 2022
I first met Wes Ely in 2016, when I wrote about ICU delirium and Ely’s attempts, as a critical-care physician at Vanderbilt University Medical Center, to urge fellow health care workers to rethink the use of heavy sedation in ICUs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 24, 2024
Returning home after five months in the hospital, the real journey began : How do we best care for and support our daughter, who cannot do any daily activities on her own, cannot walk or talk, and has become cognitively impaired? What used to be the organized chaos of caring for three young children became just chaos.
IDStewardship
APRIL 30, 2023
Ask yourself, if I do not make this improvement to this drug regimen, will someone else do it and will the patient have a worse time without the improvement? See if they do not mind sharing which plan they have and what they have learned from it. It is a totally different game now. ” mentality.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development? A recent draft from the FDA provides valuable insight.
STAT
MAY 1, 2024
Can you describe for us what the Living Brain Project has accomplished, to date, and what promise the investigators feel it holds for future brain research? As part of its reporting on Mount Sinai and the Living Brain Project, STAT sent a list of written questions to Mount Sinai. Below is a copy of the questions and responses.
STAT
MARCH 25, 2024
We basically put access out there as this talisman of hope, but we don’t compel the companies that give us answers about what these drugs do in our bodies.” These days, though, Gonsalves sounds uneasy — if not mournful — of the world he helped build.
Expert insights. Personalized for you.
104 
Let's personalize your content